Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study – Report 2

Acta Ophthalmologica

Volumn 94, Issue 6, 2016, Pages e442-e453

  Cachulo, Maria da Luz ^a,b,c   Laíns, Inês ^a,c   Lobo, Conceição ^a,b,c   Figueira, João ^a,b,c   Ribeiro, Luísa ^b,c   Marques, João P ^a   Costa, José ^a   Vieira, António ^d   Rodrigues, João ^e   Alves, Dalila ^b   Nunes, Sandrina ^b   Costa, Miguel ^b   Rodrigues, Victor ^c   Cunha Vaz, José ^b   Delcourt, Cecile ^f   Silva, Rufino ^a,b,c  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d Primary Health Care Center of Mira   (Portugal)

^e Primary Health Care Unit of Lousã   (Portugal)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

age related macular degeneration; prevalence; risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIGITAL IMAGING; EYE PHOTOGRAPHY; FAMILY HISTORY; FEMALE; GEOGRAPHIC ATROPHY; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPHTHALMOLOGY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PORTUGAL; PORTUGUESE (CITIZEN); PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RISK ASSESSMENT; SEASHORE; SEX DIFFERENCE; SMOKING; VERY ELDERLY;

EID: 84984636534     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12950     Document Type: Article

References (56)

1. Age-Related Eye Disease Study Research Group (2001): The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132: 668–681.
2. Amirul Islam FM, Chong EW, Hodge AM et al. (2014): Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology 121: 1428–1434.e2.
3. Augood CA, Vingerling JR, de Jong PT et al. (2006): Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124: 529–535.
4. Berrigan D, Dodd K, Troiano RP, Krebs-Smith SM & Barbash RB (2003): Patterns of health behavior in U.S. adults. Prev Med 36: 615–623.
5. Bird AC, Bressler NM, Bressler SB et al. (1995): An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367–374.
6. Cachulo MD, Lobo C, Figueira J et al. (2015): Prevalence of age-related macular degeneration in Portugal: the Coimbra Eye Study – Report 1. Ophthalmologica 233: 119–127.
7. Carresi C, Cruciani F, Paolucci F, Curto T, Mazzeo L, Cuozzo G, Moramarco A & Gharbiya M (2009): Montelparo study: risk factors for age-related macular degeneration in a little rural community in Italy. Clin Ter 160: e43–e51.
8. Chakravarthy U, Augood C, Bentham GC et al. (2007): Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114: 1157–1163.
9. Chakravarthy U, Wong TY, Fletcher A et al. (2010): Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10: 31.
10. Chiu CJ, Chang ML, Zhang FF, Li T, Gensler G, Schleicher M & Taylor A (2014): The relationship of major American dietary patterns to age-related macular degeneration. Am J Ophthalmol 158: 118–127 e111.
11. Coleman HR, Chan CC, Ferris FL 3rd & Chew EY (2008): Age-related macular degeneration. Lancet 372: 1835–1845.
12. Coleman AL, Seitzman RL, Cummings SR et al. (2010): The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. Am J Ophthalmol 149: 160–169.
13. Dallongeville J, Marecaux N, Fruchart JC & Amouyel P (1998): Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 128: 1450–1457.
14. Delcourt C, Diaz JL, Ponton-Sanchez A & Papoz L (1998): Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 116: 1031–1035.
15. Delcourt C, Korobelnik JF, Barberger-Gateau P et al. (2010): Nutrition and age-related eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study. J Nutr Health Aging 14: 854–861.
16. Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H & Njolstad I (2012): Prevalence of age-related macular degeneration in elderly Caucasians: the Tromso Eye Study. Ophthalmology 119: 1737–1743.
17. Evans JR (2001): Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227–253.
18. Galan I, Rodriguez-Artalejo F, Diez-Ganan L, Tobias A, Zorrilla B & Gandarillas A (2006): Clustering of behavioural risk factors and compliance with clinical preventive recommendations in Spain. Prev Med 42: 343–347.
19. Hercberg S, Galan P, Preziosi P, Alfarez MJ & Vazquez C (1998): The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers. Nutrition 14: 513–520.
20. Holick CN, Michaud DS, Stolzenberg-Solomon R, Mayne ST, Pietinen P, Taylor PR, Virtamo J & Albanes D (2002): Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol 156: 536–547.
21. Hyman L & Neborsky R (2002): Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 13: 171–175.
22. Jonas JB, George R, Asokan R et al. (2014): Prevalence and causes of vision loss in Central and South Asia: 1990–2010. Br J Ophthalmol 98: 592–598.
23. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K & Bird AC (2003): The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol 121: 379–385.
24. Jonasson F, Arnarsson A, Eiriksdottir G et al. (2011): Prevalence of age-related macular degeneration in old persons: age, Gene/environment Susceptibility Reykjavik Study. Ophthalmology 118: 825–830.
25. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT & Bird AC; Genetic Factors in AMD Study. (2006): Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90: 75–80.
26. Klein R, Davis MD, Magli YL, Segal P, Klein BE & Hubbard L (1991): The Wisconsin age-related maculopathy grading system. Ophthalmology 98: 1128–1134.
27. Klein BE, Klein R & Linton KL (1992a): Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 99: 546–552.
28. Klein R, Klein BE & Linton KL (1992b): Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99: 933–943.
29. Klein R, Klein BE, Tomany SC & Moss SE (2002): Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156: 589–598.
30. Klein R, Klein BE, Knudtson MD et al. (2006): Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113: 373–380.
31. Knoops KT, de Groot LC, Fidanza F, Alberti-Fidanza A, Kromhout D & van Staveren WA (2006): Comparison of three different dietary scores in relation to 10-year mortality in elderly European subjects: the HALE project. Eur J Clin Nutr 60: 746–755.
32. Koh WP, Yuan JM, Sun CL, Lee HP & Yu MC (2005): Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers. J Nutr 135: 2473–2477.
33. Lechanteur YT, van de Ven JP, Smailhodzic D et al. (2012): Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration. Invest Ophthalmol Vis Sci 53: 5846–5852.
34. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A & de Jong PT (2003): The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121: 519–526.
35. Marques JP, Costa M, Melo P, Oliveira CM, Pires I, Cachulo ML, Figueira J & Silva R (2013): Ocular risk factors for exudative AMD: a novel semiautomated grading system. ISRN Ophthalmol 2013: 464218.
36. Mitchell P, Smith W, Attebo K & Wang JJ (1995): Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102: 1450–1460.
37. Mitchell P, Wang JJ, Smith W & Leeder SR (2002): Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 120: 1357–1363.
38. Ness AR & Powles JW (1997): Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol 26: 1–13.
39. OECD (2012): Health at a Glance: Europe. OECD Publishing, Paris. Available at: http://www.oecdilibrary.org/social-issues-migration-health/health-at-a-glance-europe-2012_9789264183896-en
40. Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y & Kubota T (2001): Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85: 1153–1157.
41. Padrao P, Lunet N, Santos AC & Barros H (2007): Smoking, alcohol, and dietary choices: evidence from the Portuguese National Health Survey. BMC Public Health 7: 138.
42. Pagliarini S, Moramarco A, Wormald RP, Piguet B, Carresi C, Balacco-Gabrieli C, Sehmi KS & Bird AC (1997): Age-related macular disease in rural southern Italy. Arch Ophthalmol 115: 616–622.
43. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD & Resnikoff S (2004): 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 11: 67–115.
44. Piermarocchi S, Segato T, Scopa P, Masetto M, Ceca S, Cavarzeran F, Peto T & Group PS (2011): The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol 18: 129–136.
45. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A & Owen CG (2012): Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119: 571–580.
46. Smith W, Assink J, Klein R et al. (2001): Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108: 697–704.
47. Spanish Eyes Epidemiological Study Group (2011): Prevalence of age-related macular degeneration in Spain. Br J Ophthalmol 95: 931–936.
48. Steinmetz KA & Potter JD (1996): Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96: 1027–1039.
49. Tan JS, Mitchell P, Kifley A, Flood V, Smith W & Wang JJ (2007): Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 125: 1089–1095.
50. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I & Kelly SP (2005): Smoking and age-related macular degeneration: a review of association. Eye (Lond) 19: 935–944.
51. Tomany SC, Wang JJ, Van Leeuwen R et al. (2004): Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111: 1280–1287.
52. Topouzis F, Coleman AL, Harris A et al. (2006): Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study. Am J Ophthalmol 142: 1076–1079.
53. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR & McCarty CA (2000): The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107: 1593–1600.
54. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP & Los Angeles Latino Study Eye Group (2004): Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology 111: 1288–1297.
55. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE & de Jong PT (1995a): Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142: 404–409.
56. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF & de Jong PT (1995b): The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205–210.